Statement Issued By The Ministry Of Public Health

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 2000IU	2000IU	Injectable powder for solution+solvent	286,711,575 L.L
R05CB13	PULMOZYME	BioTech	Dornase alfa (desoxyribonuclease) - 2.5mg/2.5ml	2.5mg/2.5ml	Inhalation solution	L.L
J07BK01	VARICELLA VACCINE LIVE	BioTech	Varicella-herpes zoster virus (Oka strain), grown in human diploid cells (SV-cell line), live attenuated -		Injectable suspension	3,104,276 L.L
L01FE02	VECTIBIX	BioTech	Panitumumab - 400mg/20ml	400mg/20ml	Injectable concentrated solution	L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 2mg	2mg (100KIU)	Injectable powder for solution+diluent	105,957,406 L.L
L01FE02	VECTIBIX	BioTech	Panitumumab - 100mg/5ml	100mg/5ml	Injectable concentrated solution	L.L
B02BD08	ARYOSEVEN RT	BioTech	Eptacog alfa - 1mg	1mg	Injectable powder for solution+diluent	16,902,713 L.L
B02BX04	NPLATE	BioTech	Romiplostim - 250mcg	250mcg	Injectable powder for solution	L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 1mg	1mg (50KIU)	Injectable powder for solution+diluent	57,890,287 L.L
L01FD02	PERJETA 420MG	BioTech	Pertuzumab - 420mg/14ml	420mg/14ml	Injectable concentrate for solution	L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 5mg	5mg (250KIU)	Injectable powder for solution+diluent	264,894,762 L.L
B02BD08	RECOFACT VII	BioTech	Eptacog alfa (activated) recombinant - 1.2mg	1.2mg	Injectable powder for solution+diluent	47,533,131 L.L
J07CA09	HEXAXIM	BioTech	Diphteria Toxoid - ?20IU/0.5ml, Tetanus toxoid - ?40IU/0.5ml, Bordetella Pertussis Antigens: toxoid - 25mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, Hepatitis B, surface antigen - 10mcg/0.5ml, H. Influenza type b polysaccharide1 ,2 - 12mcg/0.5ml, 1 conjugated to tetanus protein - 22-36mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - 0.6mg		Injectable suspension	4,462,901 L.L
L01FD03	KADCYLA	BioTech	Trastuzumab emtansine - 100mg	100mg	Injectable powder for concentrate for solution	L.L
L01FD03	KADCYLA	BioTech	Trastuzumab emtansine - 160mg	160mg	Injectable powder for concentrate for solution	L.L
B02BX04	NPLATE	BioTech	Romiplostim - 250mcg	250mcg	Injectable powder for solution	67,369,332 L.L
L01FX04	YERVOY	BioTech	Ipilimumab - 50mg/10ml	50mg/10ml	Injectable solution	L.L
L01FX05	ADCETRIS	BioTech	Brentuximab Vedotin - 50mg	50mg	Injectable powder for concentrate for solution	L.L
L01FA03	GAZYVA	BioTech	Obinutuzumab - 1000mg/40ml	1000mg/40ml	Injectable concentrate for solution	L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 60mg/0.4ml	60mg/0.4ml	Injectable solution	441,042,377 L.L
L01FF02	KEYTRUDA	BioTech	Pembrolizumab - 100mg/4ml	100mg/4ml	Injectable solution	L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 30mg/ml	30mg/ml	Injectable solution	224,585,721 L.L
L04AA33	ENTYVIO	BioTech	Vedolizumab - 300mg	300mg	Injectable powder for concentrate for solution	152,492,033 L.L
A16AB07	MYOZYME	BioTech	Alglucosidase alfa, recombinant human acid - 50mg	50mg	Injectable powder for concentrate for solution	L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 150mg/ml	150mg/ml	Injectable solution	716,437,779 L.L
L04AA33	ENTYVIO	BioTech	Vedolizumab - 108mg	108mg	Injectable solution	88,955,869 L.L
L01FF01	OPDIVO	BioTech	Nivolumab - 100mg/10ml	100mg/10ml	Injectable solution	L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 105mg/0.7ml	105mg/0.7ml	Injectable solution	577,741,643 L.L
L04AA33	ENTYVIO	BioTech	Vedolizumab - 108mg	108mg	Injectable solution	88,955,869 L.L
L01FF01	OPDIVO	BioTech	Nivolumab - 40mg/4ml	40mg/4ml	Injectable solution	L.L